Savvy Trades and Investments

[nelson1234]

OMIC not saying it will happen, but I have seen other cash-rich dinky biotechs 'seeking strategic alternatives to maximize shareholder value' (although these other one's did not have a cash offer on the table) decide to use their cash to buy some other piece of shite dinky biotech. That way, they are able to keep their huge salaries. I have not looked at execs level of ownership here, if they do own a lot then selling out may be better for them.